Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Extracellular vesicle-associated IGF2BP3 tunes Ewing sarcoma cell migration and affects PI3K/Akt pathway in neighboring cells.
Mancarella C, Giusti V, Caldoni G, Laginestra MA, Parra A, Toracchio L, Giordano G, Roncuzzi L, Piazzi M, Blalock W, Columbaro M, De Feo A, Scotlandi K. Mancarella C, et al. Among authors: laginestra ma. Cancer Gene Ther. 2023 Sep;30(9):1285-1295. doi: 10.1038/s41417-023-00637-8. Epub 2023 Jun 23. Cancer Gene Ther. 2023. PMID: 37353558 Free PMC article.
IDH mutations in G2-3 conventional central bone chondrosarcoma: a mono institutional experience.
Setola E, Benini S, Righi A, Gamberi G, Carretta E, Ferrari C, Avnet S, Palmerini E, Magagnoli G, Gambarotti M, Lollini PL, Cesari M, Cocchi S, Paioli A, Longhi A, Scotlandi K, Laginestra MA, Donati DM, Baldini N, Ibrahim T. Setola E, et al. Among authors: laginestra ma. BMC Cancer. 2023 Sep 26;23(1):907. doi: 10.1186/s12885-023-11396-y. BMC Cancer. 2023. PMID: 37752419 Free PMC article.
A global collaboRAtive study of CIC-rearranged, BCOR::CCNB3-rearranged and other ultra-rare unclassified undifferentiated small round cell sarcomas (GRACefUl).
Palmerini E, Gambarotti M, Italiano A, Nathenson MJ, Ratan R, Dileo P, Provenzano S, Jones RL, DuBois SG, Martin-Broto J, de Alava E, Baldi GG, Grignani G, Ferraresi V, Brunello A, Paoluzzi L, Bertulli R, Hindi N, Montemurro M, Rothermundt C, Cocchi S, Salguero-Aranda C, Donati D, Martin JD, Abdelhamid Ahmed AH, Mazzocca A, Carretta E, Cesari M, Pierini M, Righi A, Sbaraglia M, Laginestra MA, Scotlandi K, Dei Tos AP, Ibrahim T, Stacchiotti S, Vincenzi B. Palmerini E, et al. Among authors: laginestra ma. Eur J Cancer. 2023 Apr;183:11-23. doi: 10.1016/j.ejca.2023.01.003. Epub 2023 Jan 18. Eur J Cancer. 2023. PMID: 36791667
Oncogenic Vav1-Myo1f induces therapeutically targetable macrophage-rich tumor microenvironment in peripheral T cell lymphoma.
Cortes JR, Filip I, Albero R, Patiño-Galindo JA, Quinn SA, Lin WW, Laurent AP, Shih BB, Brown JA, Cooke AJ, Mackey A, Einson J, Zairis S, Rivas-Delgado A, Laginestra MA, Pileri S, Campo E, Bhagat G, Ferrando AA, Rabadan R, Palomero T. Cortes JR, et al. Among authors: laginestra ma. Cell Rep. 2022 Apr 19;39(3):110695. doi: 10.1016/j.celrep.2022.110695. Cell Rep. 2022. PMID: 35443168 Free PMC article.
Integrated Molecular Characterization of Patient-Derived Models Reveals Therapeutic Strategies for Treating CIC-DUX4 Sarcoma.
Carrabotta M, Laginestra MA, Durante G, Mancarella C, Landuzzi L, Parra A, Ruzzi F, Toracchio L, De Feo A, Giusti V, Pasello M, Righi A, Lollini PL, Palmerini E, Donati DM, Manara MC, Scotlandi K. Carrabotta M, et al. Among authors: laginestra ma. Cancer Res. 2022 Feb 15;82(4):708-720. doi: 10.1158/0008-5472.CAN-21-1222. Cancer Res. 2022. PMID: 34903601 Free PMC article.
Targeting CD99 Compromises the Oncogenic Effects of the Chimera EWS-FLI1 by Inducing Reexpression of Zyxin and Inhibition of GLI1 Activity.
Balestra T, Manara MC, Laginestra MA, Pasello M, De Feo A, Bassi C, Guerzoni C, Landuzzi L, Lollini PL, Donati DM, Negrini M, Magnani M, Scotlandi K. Balestra T, et al. Among authors: laginestra ma. Mol Cancer Ther. 2022 Jan;21(1):58-69. doi: 10.1158/1535-7163.MCT-21-0189. Epub 2021 Oct 19. Mol Cancer Ther. 2022. PMID: 34667115
Restriction Factors expression decreases in HIV-1 patients after cART.
D'Urbano V, Bertoldi A, Re MC, De Crignis E, Tamburello M, Primavera A, Laginestra MA, Zanasi N, Calza L, Viale PL, Lazzarotto T, Bon I, Gallinella G. D'Urbano V, et al. Among authors: laginestra ma. New Microbiol. 2021 Apr;44(2):95-103. Epub 2021 May 1. New Microbiol. 2021. PMID: 33978194 Free article.
Corrigendum: Denatonium as a Bitter Taste Receptor Agonist Modifies Transcriptomic Profile and Functions of Acute Myeloid Leukemia Cells.
Salvestrini V, Ciciarello M, Pensato V, Simonetti G, Laginestra MA, Bruno S, Pazzaglia M, De Marchi E, Forte D, Orecchioni S, Martinelli G, Bertolini F, Méndez-Ferrer S, Adinolfi E, Di Virgilio F, Cavo M, Curti A. Salvestrini V, et al. Among authors: laginestra ma. Front Oncol. 2021 Apr 8;11:668460. doi: 10.3389/fonc.2021.668460. eCollection 2021. Front Oncol. 2021. PMID: 33898324 Free PMC article.
MicroRNA profiling of blastic plasmacytoid dendritic cell neoplasm and myeloid sarcoma.
Sapienza MR, Fuligni F, Melle F, Tabanelli V, Indio V, Laginestra MA, Motta G, Mazzara S, Cerroni L, Pileri A, Facchetti F, Paulli M, Cascione L, Laganà A, Berti E, Ferracin M, Agostinelli C, Sabattini E, Croce CM, Pileri SA. Sapienza MR, et al. Among authors: laginestra ma. Hematol Oncol. 2020 Dec;38(5):831-833. doi: 10.1002/hon.2782. Epub 2020 Aug 14. Hematol Oncol. 2020. PMID: 33405278 No abstract available.
37 results